Valuation: EQL Pharma AB

Market Cap 608M 62.72M 55.08M 51.23M 47.01M 88.32M 6.04B 89.69M 238M 2.97B 235M 230M 10.27B P/E 2027 *
33.8x
P/E 2028 * 8.34x
Enterprise Value 989M 102M 89.59M 83.31M 76.45M 144M 9.82B 146M 387M 4.83B 383M 375M 16.7B EV / Sales 2027 *
2x
EV / Sales 2028 * 1.53x
Free-Float
38.91%
Yield 2027 *
-
Yield 2028 * -
1 day+0.24%
1 week-3.74%
Current month-13.08%
1 month-10.43%
3 months-59.37%
6 months-63.80%
Current year-64.36%
1 week 19.64
Extreme 19.64
21.6
1 month 19.64
Extreme 19.64
24.75
Current year 19.64
Extreme 19.64
67.5
1 year 19.64
Extreme 19.64
98.6
3 years 19.64
Extreme 19.64
98.6
5 years 19.64
Extreme 19.64
98.6
10 years 6.35
Extreme 6.35
98.6
Manager TitleAgeSince
Chief Executive Officer 40 2022-08-16
Director of Finance/CFO 51 2026-03-31
Chief Operating Officer 48 2022-08-16
Director TitleAgeSince
Chairman 61 2022-08-16
Chairman 59 -
Director/Board Member 53 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
3/27/26 Sell

Chief Executive Officer

24,066 0.0815%
12/30/25 Buy

Executive/Senior Manager

1,000 0.0034%
12/23/25 Buy

Chief Operating Officer

19,225 0.0651%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%-3.74%-78.78%-23.42% 62.72M
-1.33%-0.59%-23.16%-31.29% 15.05B
-2.62%-0.60%-30.99%-36.86% 6.88B
+0.63%-2.90%-22.44%-8.50% 5.91B
-1.00%+4.56%-10.88%-30.58% 3.9B
+0.66%+1.55%-29.10%-47.69% 3.16B
-1.55%-0.92%+7.04%-32.10% 3.09B
+0.71%-7.44%-41.90%-20.28% 2.96B
+1.72%+3.47%-13.21%+3.25% 2.63B
+2.56%-0.17%+96.84% - 2.56B
Average +0.00%-1.30%-14.66%-25.28% 4.62B
Weighted average by Cap. -0.60%-0.99%-15.64%-27.43%

Financials

2027 *2028 *
Net sales 495M 51.03M 44.82M 41.69M 38.25M 71.87M 4.91B 72.98M 193M 2.42B 192M 187M 8.35B 664M 68.46M 60.13M 55.92M 51.31M 96.41M 6.59B 97.9M 259M 3.24B 257M 251M 11.21B
Net income 18M 1.86M 1.63M 1.52M 1.39M 2.61M 179M 2.65M 7.03M 87.86M 6.97M 6.82M 304M 73M 7.53M 6.61M 6.15M 5.64M 10.6M 725M 10.76M 28.52M 356M 28.25M 27.65M 1.23B
Net Debt 381M 39.28M 34.5M 32.09M 29.44M 55.32M 3.78B 56.17M 149M 1.86B 147M 144M 6.43B 406M 41.86M 36.76M 34.19M 31.37M 58.95M 4.03B 59.86M 159M 1.98B 157M 154M 6.85B
Logo EQL Pharma AB
EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.
Employees
60
Date Price Change Volume
26-07-24 SEK 20.60 +0.24% 33,295
26-07-23 SEK 20.55 -0.72% 18,528
26-07-22 SEK 20.70 -0.24% 76,913
26-07-21 SEK 20.75 +1.97% 34,494
26-07-20 SEK 20.35 -4.91% 51,677
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise